[Features of the immune status in acute pancreatitis].
Tarasenko
V S
VS
Smoliagin
A I
AI
Kubyshkin
V A
VA
D000208:Acute Disease; D000818:Animals; D000936:Antigen-Antibody Complex / Q000276:immunology; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001323:Autoantibodies / Q000276:immunology; D001769:Blood / Q000528:radiation effects; D003165:Complement System Proteins / Q000276:immunology; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000209:etiology; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007231:Infant, Newborn; D007376:Interleukin-2 / Q000276:immunology / Q000627:therapeutic use; D018655:Lymphocyte Count; D009102:Multiple Organ Failure / Q000209:etiology / Q000276:immunology / Q000628:therapy; D010195:Pancreatitis / Q000276:immunology* / Q000503:physiopathology / Q000601:surgery / Q000628:therapy; D019283:Pancreatitis, Acute Necrotizing / Q000276:immunology / Q000503:physiopathology; D010956:Plasmapheresis; D051381:Rats; D011994:Recombinant Proteins / Q000627:therapeutic use; D012128:Respiratory Distress Syndrome / Q000209:etiology / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014466:Ultraviolet Rays
D000936:Antigen-Antibody Complex; D000961:Antilymphocyte Serum; D001323:Autoantibodies; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D011994:Recombinant Proteins; D003165:Complement System Proteins